Naiad is a bioinformatics startup creating novel bioactive molecules targeting G protein-coupled receptors (GPCRs), a superfamily of receptors involved in a wide range of diseases. The STYX technology they are developing and their strong capabilities in structure based drug design will enable them to build a robust pipeline of new molecules with high potential to become next generation medicines.


Click here to go back to see other startups.